ExploreWatchlistsPricing
  1. JP-listed companies
  3. Financials
  4. Income before tax

(4881)

Market cap
¥2.9B
P/E ratio
Funpep develops new medicines using functional peptides and its STEP UP drug discovery platform, focusing on treatments like SR-0379 for skin ulcers.
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndIncome before tax (Million JPY)YoY (%)
Dec 31, 2025-1,634+82.29%
Dec 31, 2024-896-4.71%
Dec 31, 2023-940-19.98%
Dec 31, 2022-1,175+72.92%
Dec 31, 2021-680+34.56%
Dec 31, 2020-505+117.43%
Dec 31, 2019-232+2556.60%
Dec 31, 2018-9-95.49%
Dec 31, 2017-194-227.64%
Dec 31, 2016152+589.90%
Dec 31, 201522

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat